Seminar, Hosted by European College of Neuropsychopharmacology (ECNP) Clinical Outcomes Network
Measuring what matters: Goal Attainment Scaling (GAS) as a personalised endpoint in clinical trials
Gunes Sevinc and Rebecca Metcalfe
Ardea Outcomes
Abstract
Personalised clinical outcome assessments are increasingly used to capture the treatment benefits that matter most to patients. Goal Attainment Scaling (GAS) quantifies individualised treatment goals; regulators including the U.S. Food and Drug Administration have recognised its responsiveness, clinical meaningfulness and patient relevance, while calling for more standardised goal setting and scoring. Gunes Sevinc and Rebecca Metcalfe present practical and methodological approaches to standardised GAS implementation in clinical research: when and why GAS is an appropriate endpoint, criteria for developing high-quality goal scales, and best practices including goal inventories, rater training, patient orientation materials and procedures for monitoring training fidelity and quality assurance, so that GAS captures meaningful outcomes in heterogeneous patient populations.